Rocket Pharmaceuticals Inc

Insider sales spike at Rocket Pharmaceuticals as shares rally – insiders selling to take profits, not fear, amid a speculative surge.

Insider selling at Rocket Pharmaceuticals signals caution: CEO and counsel liquidated shares amid a fragile stock, hinting at a possible short‑term correction or strategic pivot.

CEO’s bulk purchase of Rocket Pharma shares signals strong insider confidence amid market volatility, hinting at future upside if clinical milestones materialize.